Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

713
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
713
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.1K
Neural Regulation01:37

Neural Regulation

41.3K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
41.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Delayed-onset parkinsonism is common after isolated striatal infarcts.

Frontiers in neurology·2025
Same author

Vascular parkinsonism.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2023
Same author

A man in his fifties with increasing motor fluctuations, sleep impairment and altered mental status.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2020
Same author

GABA, but Not Bestrophin-1, Is Localized in Astroglial Processes in the Mouse Hippocampus and the Cerebellum.

Frontiers in molecular neuroscience·2020
Same author

Slc38a1 Conveys Astroglia-Derived Glutamine into GABAergic Interneurons for Neurotransmitter GABA Synthesis.

Cells·2020
Same author

Dysfunction of homeostatic control of dopamine by astrocytes in the developing prefrontal cortex leads to cognitive impairments.

Molecular psychiatry·2018

Related Experiment Video

Updated: Nov 13, 2025

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.8K

Parkinson's Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy?

Vidar Gundersen1

  • 1Section for Movement Disorders, Department of Neurology, Oslo University Hospital, Oslo, Norway.

Frontiers in Neuroscience
|March 15, 2021
PubMed
Summary

Brain inflammation is an early event in Parkinson's disease (PD), involving T-lymphocytes and peripheral inflammation. However, clinical trials targeting inflammation have largely failed, suggesting a complex role in neurodegeneration.

Keywords:
T-cellsalpha-synucleinbraincervical lymph nodegutmicroglia

Related Experiment Videos

Last Updated: Nov 13, 2025

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.8K

Area of Science:

  • Neuroscience
  • Immunology
  • Neurology

Background:

  • The precise cause of dopamine neuron loss in Parkinson's disease (PD) is not fully understood.
  • Growing evidence suggests that neuroinflammation plays a significant role in neurodegenerative processes.

Purpose of the Study:

  • To investigate if brain inflammation occurs early enough in PD to be a viable therapeutic target.
  • To determine if anti-inflammatory strategies could effectively slow neurodegeneration in PD.
  • To explore the involvement of T-lymphocytes and peripheral inflammation in PD pathogenesis.

Main Methods:

  • Analysis of data from human Parkinson's disease studies.
  • Review of existing research on neuroinflammation and T-lymphocyte involvement in PD.
  • Critical evaluation of clinical trial outcomes for anti-inflammatory treatments in PD.

Main Results:

  • Human PD studies indicate that brain inflammation is an early pathological event.
  • T-lymphocytes and peripheral inflammation are implicated in the neurodegenerative process of PD.
  • Clinical trials targeting inflammation in PD have yielded disappointing results.

Conclusions:

  • Brain inflammation is an early feature of Parkinson's disease.
  • While inflammation is present early, targeting it with anti-inflammatory agents has not proven effective in clinical trials.
  • Further research is needed to understand the complex role of inflammation and T-lymphocytes in PD and to develop successful therapeutic strategies.